|
Annual Report to shareholders
|
30 June 2023 at 1:30pm
|
|
TruScreen Preliminary Final Results March 2023
|
30 May 2023 at 3:20pm
|
|
CSCCP Screening Guideline to Include TruScreen Technology
|
16 May 2023 at 8:25am
|
|
TruScreen Recognised in Authoritative China Blue Paper
|
8 May 2023 at 8:05am
|
|
Change of Director's Interest Notice
|
8 May 2023 at 8:05am
|
|
Growing Recognition for TruScreen
|
1 May 2023 at 8:45am
|
|
Director Disclosure Notices X 4
|
24 March 2023 at 9:25am
|
|
Appendix 2A
|
22 March 2023 at 11:15am
|
|
TruScreen Rights Offer closes
|
21 March 2023 at 8:05am
|
|
Outstanding Clinical Evaluation Results from Saudi Arabia
|
14 March 2023 at 8:40am
|
|
TruScreen Rights Issue Offer Closing Soon
|
13 March 2023 at 9:00am
|
|
China Ramps Up for Public Health Check Centres
|
8 March 2023 at 8:00am
|
|
TruScreen Raises $600,000 in Initial Share Placement
|
3 March 2023 at 8:05am
|
|
TruScreen Rights Issue Offer Opens
|
28 February 2023 at 9:20am
|
|
TruScreen Pro Rata Renounceable Rights Issue Offer Document
|
24 February 2023 at 12:10pm
|
|
Cleansing Notice
|
17 February 2023 at 4:10pm
|
|
TruScreen to Launch Pro Rata Renounceable Rights Issue
|
17 February 2023 at 8:05am
|
|
Commercial Update
|
15 February 2023 at 8:05am
|
|
Distributor Update December 2022
|
19 December 2022 at 9:05am
|
|
Change in Directors Interest Notice X 2
|
5 December 2022 at 8:00am
|
|
Half Yearly Report and Accounts
|
29 November 2022 at 8:45am
|
|
TruScreen Market Update November 2022
|
22 November 2022 at 8:00am
|
|
TruScreen Stakeholder Newsletter November 2022
|
9 November 2022 at 8:00am
|
|
Hosts Global Medical Symposium, Expands Reach in Vietnam
|
2 November 2022 at 8:00am
|
|
Change of Director's Interest Notice
|
31 October 2022 at 10:30am
|
|
Change of Director's Interest Notice
|
10 October 2022 at 8:00am
|
|
Dr Beata Edling Appointed CEO of TruScreen Group
|
6 October 2022 at 8:00am
|
|
Results of Meeting
|
6 September 2022 at 1:15pm
|
|
Annual Shareholder Meeting Presentation
|
6 September 2022 at 9:20am
|
|
Signs 5 Year Manufacturing Agreement for Critical SUS Supply
|
1 September 2022 at 8:05am
|
|
Change of Director's Interest Notice
|
15 August 2022 at 8:05am
|
|
Relaunch of TruScreen Devices in Xinjiang Uygur Region
|
10 August 2022 at 9:25am
|
|
TRU based Cervical Cancer Screening Clinic Opens Mexico City
|
3 August 2022 at 9:45am
|
|
Notice of Annual General Meeting/Proxy Form
|
1 August 2022 at 2:45pm
|
|
Director Nominations Closing Date
|
18 July 2022 at 2:55pm
|
|
Change of Director's Interest Notice
|
5 July 2022 at 10:35am
|
|
Annual Report to shareholders
|
30 June 2022 at 1:20pm
|
|
Change of Director's Interest Notice
|
16 June 2022 at 3:55pm
|
|
Change of Director's Interest Notice
|
16 June 2022 at 9:55am
|
|
Change of Director's Interest Notice
|
14 June 2022 at 8:05am
|
|
Change of Director's Interest Notice X 2
|
2 June 2022 at 9:05am
|
|
Preliminary Final Report
|
30 May 2022 at 8:10am
|
|
Provision for Impairment of Non Current Assets
|
27 May 2022 at 5:30pm
|
|
COGA Trial Validates TRU Cervical Cancer Screening Method
|
5 April 2022 at 8:05am
|
|
Issue of Options - Capital Change Notice
|
4 March 2022 at 10:00am
|
|
TruScreen Achieves Significant Milestones with Distributors
|
3 March 2022 at 8:00am
|
|
Change of Directors Interest Notice X 2
|
29 December 2021 at 12:00pm
|
|
Issue of Options - Capital Change Notice
|
29 December 2021 at 12:00pm
|
|
TruScreen Makes Progress in Key Markets Worldwide
|
15 December 2021 at 8:00am
|
|
Half Year Accounts
|
29 November 2021 at 10:25am
|
